급성기 뇌졸중 치료: 2007년 최신지견

참고문헌 (29)

1. Adams HP Jr, "Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association", American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists, 2007, pp.38, 1655~1711
2. Kidwell CS, "Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS)", Stroke, 31, pp.71~76 (2000)
3. Kothari RU, "Cincinnati Prehospital Stroke Scale: reproducibility and validity", Ann Emerg Med, 33, pp.373~378 (1999)
4. Wojner-Alexandrov AW, "Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO)", Stroke, 36, pp.1512~1518 (2005)
5. Wahlgren N, "Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke- Monitoring Study (SITS-MOST): an observational study", Lancet, 369, pp.275~282 (2007)
6. Hacke W, "Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators", Lancet, 352, pp.1245~1251 (1998)
7. Hacke W, "Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)", JAMA, 274, pp.1017~1025 (1995)
8. Furlan AJ, "Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset", Stroke, 37, pp.1227~1231 (2006)
9. Hacke W, "The Desmoteplase in Acute Ischemic Stroke Trial(DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase", Stroke, 36, pp.66~73 (2005)
10. 3Albers GW, "Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study", Ann Neurol, 60, pp.508~517 (2006)
11. Lansberg MG, "Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke", Stroke, 38, pp.2275~2278 (2007)
12. Lansberg MG, "Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in DEFUSE", Stroke, 38, pp.1826~1830 (2007)
13. Dávalos A, "The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction", Neurology, 62, pp.2187~2192 (2004)
14. Furlan A, "Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism", JAMA, 282, pp.2003~2011 (1999)
15. Ogawa A, "Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan", Stroke, 38, pp.2633~2639 (2007)
16. IMS II Trial Investigators, "The Interventional Management of Stroke (IMS) II Study", Stroke, 38, pp.2127~2135 (2007)
17. IMS Trial Investigators, "Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study", Stroke, 35, pp.904~911 (2004)
18. Rha JH, "The impact of recanalization on ischemic stroke outcome: a meta-analysis", Stroke, 38, pp.967~973 (2007)
19. Abciximab Emergent Stroke Treatment Trial (AbesTT) Investigators, "Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial", Stroke, 36, pp.880~890 (2005)
20. Adams HP Jr, "Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)", Stroke, 39, pp.87~99 (2008)
21. Kennedy J, "Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial", Lancet Neurol, 6, pp.961~969 (2007)
22. Vahedi K, "Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials", Lancet Neurol, 6, pp.215~222 (2007)
23. Shuaib A, "NXY-059 for the treatment of acute ischemic stroke", N Engl J Med, 357, pp.562~571 (2007)
24. Lees KR, "NXY- 059 for acute ischemic stroke", N Engl J Med, 354, pp.588~600 (2006)
25. Lyden PD, "Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial", Stroke, 38, pp.2262~2269 (2007)
26. Kelly J, "Venous thromboembolism after acute stroke", Stroke, 32, pp.262~267 (2001)
27. McCarthy ST, "Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke", Age Ageing, 15, pp.84~88 (1986)
28. McCarthy ST, "Lowdose heparin as a prophylaxis against deep-vein thrombosis after acute stroke", Lancet, 2, pp.800~801 (1977)
29. Sherman DG, "The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison", Lancet, 369, pp.1347~1355 (2007)

관련 논문AI추천